cyclic heptapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-07-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
For prolonged treatment of lupus or rheumatoid arthritis, adverse effects include the acute symptoms, plus altered eye pigmentation, acne, anemia, bleaching of hair, blisters in mouth and eyes, blood disorders, cardiomyopathy, convulsions, vision difficulties, diminished reflexes, emotional changes, excessive coloring of the skin, hearing loss, hives, itching, liver problems or liver failure, loss of hair, muscle paralysis, weakness or atrophy, nightmares, psoriasis, reading difficulties, tinnitus, skin inflammation and scaling, skin rash, vertigo, weight loss, and occasionally urinary incontinence. Hydroxychloroquine can worsen existing cases of both psoriasis and porphyria. Children may be especially vulnerable to developing adverse effects from hydroxychloroquine overdoses.
As skin ages, it becomes thinner and more easily damaged. Intensifying this effect is the decreasing ability of skin to heal itself as a person ages. Among other things, skin ageing is noted by a decrease in volume and elasticity. There are many internal and external causes to skin ageing. For example, ageing skin receives less blood flow and lower glandular activity. A validated comprehensive grading scale has categorized the clinical findings of skin ageing as laxity (sagging), rhytids (wrinkles), and the various facets of photoageing, including erythema (redness), and telangiectasia, dyspigmentation (brown discolouration), solar elastosis (yellowing), keratoses (abnormal growths) and poor texture. Cortisol causes degradation of collagen, accelerating skin ageing. Anti-ageing supplements are used to treat skin ageing.
with TA the total concentration of species A. Note that it is customary to omit the ionic charges when writing and using these equations. When the equilibrium constants are known and the total concentrations are specified there are two equations in two unknown "free concentrations" [A] and [H]. This follows from the fact that [HA] = β1[A] [H], [H2A] = β2[A] [H]2 and [OH] = Kw[H]−1
The term in situ does not appear in Classical Latin. Its earliest recorded use is in Late Latin, with the first known instance in the writings of Augustine of Hippo (354–430 AD). It became widely used in Medieval Latin. In English, the earliest known usage dates to the mid-17th century; the Oxford English Dictionary cites the first appearance in 1648, in William Molins' anatomical text Myskotomia. The usages in scientific literature increased from the late 19th century onward, initially in medicine and engineering, including geological surveys and petroleum extraction. During this period, the term described analyses conducted within the living human body or inside oil wells, among other applications. In situ entered French medical discourse by 1877 in the Journal de médecine et de chirurgie pratiques ('Journal of Practical Medicine and Surgery'). The compound term carcinoma in situ, referring to abnormal cells that are confined to their original location without invasion of surrounding tissue, was first used in a 1932 paper by U.S. surgical pathologist Albert C. Broders. The concept of in situ in contemporary art developed in the late 1960s and 1970s as a framework for artworks created specifically for a given space. By the mid-1980s, the term was adopted in materials science, particularly in the field of heterogeneous catalysis, where a catalyst in one phase facilitates a chemical reaction in a different phase. Its usage later expanded beyond catalysis and is now applied across various disciplines within materials science.
==== Attitude to liberalism and personal relations ==== The early focus of the Black Consciousness Movement (BCM) was on criticising anti-racist white liberals and liberalism itself, accusing it of paternalism and being a "negative influence" on black Africans. In one of his first published articles, Biko stated that although he was "not sneering at the [white] liberals and their involvement" in the anti-apartheid movement, "one has to come to the painful conclusion that the [white] liberal is in fact appeasing his own conscience, or at best is eager to demonstrate his identification with the black people only insofar as it does not sever all ties with his relatives on his side of the colour line." Biko and SASO were openly critical of NUSAS' protests against government policies. Biko argued that NUSAS merely sought to influence the white electorate; in his opinion, this electorate was not legitimate, and protests targeting a particular policy would be ineffective for the ultimate aim of dismantling the apartheid state. SASO regarded student marches, pickets, and strikes to be ineffective and stated it would withdraw from public forms of protest. It deliberately avoided open confrontation with the state until such a point when it had a sufficiently large institutional structure. Instead, SASO's focus was on establishing community projects and spreading Black Consciousness ideas among other black organisations and the wider black community.
Sources: en.wikipedia.org
== Toxicity == Tertiapin is a compound of the honey bee venom (apitoxin) that causes pain and signs of inflammation around the sting, but a great number of stings can be lethal (LD50 is 18-22 stings per kg for humans). An anaphylactic shock can develop if a person has an allergy to the venom. In that case even one sting can be lethal.
In 2012, 37.1% of infants under six months of age were breastfeeding exclusively, which rose to 48% in 2022. The Sustainable Development Goals target is to achieve 70% by 2030. In the United States, the rate of women beginning to breastfeed was 76% in 2009, increasing to 83% in 2015, with 58% still breastfeeding at 6 months, although only 25% were still breastfeeding exclusively. African-American women have persistently low rates of breastfeeding compared to White and Hispanic American women. In 2014, 58.1% of African-American women breastfeed in the early postpartum period, compared to 77.7% of White women and 80.6% of Hispanic women. In 2019, 84.1% of U.S women giving birth initiated breastfeeding, with 87.4%, 85.5%, 73.6%, 90.3% and 83.1% of Hispanic, White, African-American, Asian and Multiracial mothers initiating, respectively. Rates of initiation among African-American mothers varied widely by state, with lows under 53% and highs over 90%. Breastfeeding rates in different parts of China vary considerably. Rates in the United Kingdom were the lowest in the world in 2015, with only 0.5% of mothers still breastfeeding at a year, while in Germany, 23% are doing so, 56% in Brazil, and 99% in Senegal. In Australia, for children born in 2004, more than 90% were initially breastfed. In Canada, for children born in 2005–06, more than 50% were only breastfed, and more than 15% received both breastmilk and other liquids by the age of 3 months.
As in the case of women, men are more prone to develop an eating disorder if their occupation or sport emphasizes having a slim physique or lighter weight, like modeling, dancing, horse racing, wrestling, and gymnastics. Hormonal changes may also be observed in males with anorexia nervosa, with marked changes in their serum testosterone, luteinizing hormone, and follicle stimulating hormone. Such extreme endocrine disturbances can potentially result in infertility. Anorexic men are sometimes colloquially referred to as manorexic or as having bigorexia.
Elsewhere in the province, parts of Spin Boldak District were also struck. Additionally, Taliban forces' facility in Pul-e-Charkhi was also struck by the PAF. Following Pakistan's airstrikes on Kabul and Kandahar, Zabihullah Mujahid stated that the Taliban were ready to negotiate with Pakistan. On 27 February, the PAF carried out airstrikes in parts of Paktika and Laghman provinces, according to local Afghan sources. The airstrike in Laghman targeted the 201 Khalid Ibn Walid Corps, while the one in Paktika struck a house. However, according to some Afghan sources, the Taliban-led Afghan armed forces base in Paktika was the one that was struck by the PAF. Afghan local sources also report an airstrike on the Taliban-led Afghan border brigade in Paktika province. Later the same day, at around noon, the Taliban-led Afghan border brigade in Gardez was also struck by an airstrike carried out by the PAF. An additional airstrike in parts of Nangarhar was also reported by local Afghan sources. The Taliban-led Afghan armed forces base in Khost Province was also struck in the airstrikes that were carried out on 27 February. On the same day, the Taliban-led Afghan Ministry of Defense announced that it had carried out airstrikes in Pakistan targeting military sites in Faizabad, Nowshera, Jamrud, and Abbottabad. The ministry did not provide details about the type of aircraft or equipment allegedly used in the attacks. Pakistani officials, however, stated that attempts to strike in Abbottabad, Swabi, and Nowshera using small drones had been foiled using anti-drone systems.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.